SLC2A1 and neoplasm: The glycolytic process in tumor cells is intricately controlled by the PI3K/AKT signaling pathway, which plays a crucial role in upregulating proteins involved in glucose metabolism, such as glucose transporters (GLUT) and phosphofructokinase (PFK) (W et al., 2019).